Agreements reached under this partnership
Business alliance- 1
Provides “PRP with platelet function maintained”
- 2
Provides PRP using standardized preparation procedures
- 3
Provides highly safe PRP
- 4
Can be prepared from a small volume of blood
- 5
Can provide “Super Pure PRP” with minimal contamination by components other than platelets
- 6
Enables the accumulation of evidence by making the quality of PRP after preparation visible
- 7
Platelet function remains maintained even after several weeks of storage
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this matter on results for the fiscal year ending March 2027 will be minor.
| Item | Details |
|---|---|
| Name of alliance partner | 株式会社 AdipoSeeds |
| Alliance partner's business activities | Development of regenerative medicine products and other products using ASCL-PLC, a multifunctional platelet derived from adipose tissue, including treatments for refractory skin ulcers and platelet products for transfusion, with a focus on business for PRP (Platelet-Rich Plasma) therapy |
| Alliance partner's location | Shinjuku-ku, Tokyo |
| Type of alliance | Business alliance |
| Details of the alliance | Provides “PRP with platelet function maintained”, Provides PRP using standardized preparation procedures, Provides highly safe PRP, Can be prepared from a small volume of blood, Can provide “Super Pure PRP” with minimal contamination by components other than platelets, Enables the accumulation of evidence by making the quality of PRP after preparation visible, Platelet function remains maintained even after several weeks of storage |
| Contract Date | 21 July 2026 |
| Impact on Business Performance | The impact of this matter on results for the fiscal year ending March 2027 will be minor. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The alliance is intended to address issues including the lack of standardized PRP preparation procedures among medical institutions and variations in platelet quality and quantity. The companies plan to use their respective technologies to provide PRP that maintains platelet function, standardized PRP and highly safe PRP.